BIO Urges EPA to Reject petroleum industry RFS waiver petition.
Share:
Press Release Summary:
In an 11-page letter to Environmental Protection Agency (EPA) Administrator Gina McCarthy, BIO's Brent Erickson urged rejection of recent petition from American Petroleum Institute and American Fuel and Petrochemical Manufacturers for waiver of 2014 volume obligations under Renewable Fuel Standard (RFS). Erikson cited waiver seekers' blocking of investment in infrastructure and creation of marketing challenges as having created same situation from which they are requesting relief.
Original Press Release:
BIO Urges EPA to Reject Petroleum Industry's RFS Waiver Petition
WASHINGTON--The Biotechnology Industry Organization (BIO) today wrote to Environmental Protection Agency (EPA) Administrator Gina McCarthy, asking her to reject the recent petition from American Petroleum Institute and American Fuel and Petrochemical Manufacturers for a waiver of the 2014 volume obligations under the Renewable Fuel Standard (RFS). BIO emphasized that because petroleum refining companies enjoy great flexibility in planning and choosing among compliance options under the RFS, they can easily avoid causing the harm to the U.S. economy that the trade organizations foretell.
“The reality is that because they have blocked investment in infrastructure and created marketing challenges for higher blends of biofuels, the petitioners are now requesting the Administrator waive the 2014 RVOs to 9.7 percent of the domestic fuel supply. They created the very situation from which they are requesting relief.”
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, wrote in the letter:
“BIO urges the EPA to deny the joint petition for several reasons. First, the petitioners do not meet the requirements to file the joint petition. The joint petition is also premature. The petitioners cannot demonstrate harm when the 2014 renewable volume obligations (RVOs) have not even been formally proposed.”
Erickson continues the 11-page letter, writing:
“The reality is that because they have blocked investment in infrastructure and created marketing challenges for higher blends of biofuels, the petitioners are now requesting the Administrator waive the 2014 RVOs to 9.7 percent of the domestic fuel supply. They created the very situation from which they are requesting relief.
“There are a host of RFS compliance choices explained in detail below, which taken together provide obligated parties sufficient flexibility and time to plan compliance strategies for 2014 and beyond. Since these compliance options exist, obligated parties have sufficient tools to plan ahead for the accumulation of RINs to meet their 2014 RFS RVOs. While some individual refiners may choose to restrict U.S. fuel supply as a compliance strategy, market competition and the increasing production of biofuels will work in tandem so such a restriction will not harm the U.S. economy or consumers.”
Erickson concluded the letter by saying:
“EPA should deny the requests because the projected harm to the U.S. economy would stem not from the 2014 RFS RVOs, but rather from the ongoing dilatory tactics of the very parties seeking the waivers. The blend wall was anticipated five years ago at the outset of RFS implementation and obligated parties have largely chosen not to prepare for the blend wall. They have not encouraged or facilitated infrastructure investment or new fuel marketing. Instead, most of them are spending their time and advocacy trying to chill investment in greater biofuels production. This includes their filing the joint petition, which is opposed by BIO as reflected in these comments. The petitioners and their members should not be rewarded for these efforts.”
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
BIO Investor Forum
October 8-9, 2013
San Francisco, CA
BIO IPCC Conference
November 6-8, 2013
Washington, DC
BIO Convention in China
November 11-13, 2013
Beijing, China
Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 8-11, 2013
San Diego, CA
BIO CEO & Investor Conference
February 10 – 11, 2014
New York, NY
BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan
World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA
BIO International Convention
June 23-26, 2014
San Diego, CA
Contacts
Biotechnology Industry Organization
Paul Winters, 202-962-9237
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
